Smith+Nephew's PICO Single Use Negative Pressure Wound Therapy System Provides Better Clinical Outcomes Versus Standard Of Care According To Uk National Institute For Health And Care Excellence
Portfolio Pulse from Benzinga Newsdesk
The UK National Institute for Health and Care Excellence (NICE) has reconfirmed its guidance favoring Smith+Nephew's PICO Single Use Negative Pressure Wound Therapy System (sNPWT) over standard dressings for patients at high risk of surgical site infections (SSIs). This decision is based on a review of 28 new studies, showing PICO sNPWT's superior clinical outcomes and cost-effectiveness, especially in surgeries like colorectal, cardiothoracic, and vascular. The PICO sNPWT dressing, featuring AIRLOCK Technology, reduces the risk of wound complications, offering significant benefits for healthcare systems and patients.
April 04, 2024 | 3:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Smith+Nephew's PICO sNPWT has been endorsed by NICE for its superior clinical outcomes and cost-effectiveness in preventing SSIs, particularly in high-risk surgeries. This endorsement could enhance the product's adoption and reputation in healthcare systems.
The reconfirmation of NICE's guidance for Smith+Nephew's PICO sNPWT underscores its effectiveness and cost-efficiency in managing surgical site infections, which could lead to increased adoption and sales. The product's unique features and the positive review from a reputable body like NICE significantly bolster its market position and could positively impact Smith+Nephew's financial performance in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100